Nicotinamide riboside or IL-17A signaling blockers to prevent liver disorders
Oncoscience
.
2017 Feb 24;4(1-2):1-2.
doi: 10.18632/oncoscience.338.
eCollection 2017 Jan.
Authors
Ana Teijeiro
1
,
Nabil Djouder
1
Affiliation
1
Cancer Cell Biology Programme, Growth Factors, Nutrients and Cancer Group, Spanish National Cancer Research Centre, CNIO, Madrid, Spain.
PMID:
28484725
PMCID:
PMC5361639
DOI:
10.18632/oncoscience.338
No abstract available
Keywords:
HCC; IL-17A; NAD+; NASH; Nicotinamide riboside.
Publication types
Editorial